Bolivia Decreto Supremo 2905: AGEMED Created from UNIMED and CONCAMYT

1. Key takeaways

AGEMED was created by Decreto Supremo N° 2905 of September 21, 2016, as a deconcentrated unit under the Ministry of Health and Sports, with independence in administrative, financial, legal, and technical management. Under Article 2 of that decree, AGEMED was formed on the basis of UNIMED and CONCAMYT, with CONCAMYT merged into the new agency. Understanding this institutional transition explains two mismatches that recur in Bolivian applications: form numbers still follow the DINAMED and UNIMED era numbering system, while fees and procedures cite ministerial resolutions issued after 2018. GRZAN describes this phenomenon as procedural inheritance: it is neither an oversight nor an obsolete rule that can be ignored. It means an applicant must be fluent in two generations of paperwork at once, and that internal checklists should reference exact form numbers and current resolution numbers rather than agency names, because the names have changed while many instruments have carried over.

The 2016 reorganization is also the reason why the answer to a procedural question can depend on which document is consulted. A procedure page on gob.bo may describe a step using UNIMED-era terminology, a fee may be set by a 2018 ministerial resolution, and the receiving office may operate under an administrative resolution issued in 2021. None of these references is wrong; each belongs to a different layer of the transition. Applicants who understand the timeline of the reorganization can reconcile apparent contradictions quickly, while applicants who assume a single coherent canon of forms and fees tend to file appeals or clarification requests that the agency answers by pointing back to the same mixed sources.

2. Legal basis

3. Expert insights

Insight one: deconcentration produces territorial coordination, not vertical centralization. AGEMED conducts its inspection work across the 9 departments of Bolivia in coordination with the Departmental Health Services (SEDES). For importers this means that compliance at headquarters is not enough: local inspections at the place of storage will also be triggered, and the condition of a warehouse in Santa Cruz or Cochabamba can affect the standing of a registration managed from La Paz. Importer due diligence should therefore extend to the department where goods are actually held.

Insight two: the merger of CONCAMYT brings laboratory capability back inside the regulator. With the quality control laboratory for medicines and toxicology absorbed into AGEMED, sanitary registration and quality control testing are closed-loop within a single institution. The direct consequence for devices is that AGEMED has internal technical capacity to verify technical documentation and test reports, so a dossier does not pass simply because it looks complete on the surface. Claims should be supported with traceable evidence.

Insight three: the generational mixing of form numbers is a real compliance trap. Form 027 belongs to the UNIMED era numbering system, yet it continues to be used in the current AGEMED virtual procedures. A company whose standard operating procedures say AGEMED forms without citing exact numbers will generate errors during internal handovers, especially when staff rotate between markets that use different national form systems.

Insight four: independence in management does not mean isolation in practice. The decree gives AGEMED independence in administrative, financial, legal, and technical management, but the agency still works inside the ministry’s institutional orbit, and its instruments cite the ministry’s own resolutions, as Resolución Administrativa N° 001 of January 6, 2021 shows by citing the decree that created it. For an applicant, the practical reading is that authority flows in one readable chain: law, supreme decree, ministerial resolution, administrative act. When a requirement seems doubtful, locating it in that chain is the fastest way to confirm whether it is binding or merely habitual practice.

4. Practical recommendations

The three recommendations below address the risks created by the transition itself: ambiguity of document names, uneven inspection intensity across departments, and the coexistence of electronic filing with physical verification. They are cheap to adopt at project start and costly to retrofit once a submission is already under review, because any correction to an identified form or entity in a filed dossier means an exchange with the reviewing office.

Finally, the creation story of the agency explains one more practical habit worth adopting: when a Bolivian counterpart cites a requirement, ask for the instrument and the year, not just the rule. The answer will frequently be a UNIMED-era form, a 2018 fee resolution, and a current administrative instruction used together, and recording all three in the project file keeps the citation chain complete for audits and for successor project teams.

1. Always cite form numbers in SOPs, not agency names. Locate documents by identifiers such as Form 027 and Form 011 to avoid ambiguity caused by institutional reorganizations.
2. Include local inspections in importer due diligence. Beyond the operating license, verify whether the importer’s warehouse has recently passed a storage inspection by the competent SEDES.
3. File through the current AGEMED virtual procedure while keeping paper dossier capability. Bolivian procedures have been digitized, but the technical review stage may still require physical verification of samples or labeling.

5. Verification checklist

• □ Confirm that the application uses the current version of Form 027
• □ Confirm that fees are based on the current operative text of Resolución Ministerial N° 0265 of May 25, 2018
• □ Confirm the SEDES inspection record for the department where the importer’s warehouse is located
• □ Confirm whether the functions page of the AGEMED website shows any adjustment to the agency’s remit
• □ Confirm that the application is submitted through the AGEMED virtual procedure portal

Regulatory information verified as of October 29, 2026.

GRZAN supports manufacturers, importers, and authorized representatives with medical device registration in Bolivia, covering dossier preparation, local entity coordination, and regulatory strategy. Contact info@grzanglobal.com for project inquiries.